Clark Paramore

1.5k total citations
26 papers, 1.1k citations indexed

About

Clark Paramore is a scholar working on Genetics, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Clark Paramore has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 6 papers in Hematology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Clark Paramore's work include Hemoglobinopathies and Related Disorders (12 papers), Iron Metabolism and Disorders (6 papers) and Prenatal Screening and Diagnostics (3 papers). Clark Paramore is often cited by papers focused on Hemoglobinopathies and Related Disorders (12 papers), Iron Metabolism and Disorders (6 papers) and Prenatal Screening and Diagnostics (3 papers). Clark Paramore collaborates with scholars based in United States, United Kingdom and Switzerland. Clark Paramore's co-authors include Louis S. Matza, Manishi Prasad, Marco Mercader, Matthew W. Reynolds, Karin S. Coyne, Peter Zimetbaum, Susan Grandy, Kathy Fraeman, Don Robinson and Joseph G. Verbalis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Clark Paramore

25 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clark Paramore United States 11 339 195 190 134 134 26 1.1k
Signild Åsberg Sweden 18 545 1.6× 159 0.8× 74 0.4× 94 0.7× 57 0.4× 39 1.1k
T. Michelle Brown United States 17 64 0.2× 107 0.5× 95 0.5× 54 0.4× 63 0.5× 46 862
Hassan Hosseini France 20 122 0.4× 85 0.4× 56 0.3× 124 0.9× 23 0.2× 101 1.4k
Sofia Pedro United States 16 58 0.2× 119 0.6× 111 0.6× 55 0.4× 36 0.3× 38 954
Amit Kumar India 18 126 0.4× 64 0.3× 143 0.8× 134 1.0× 11 0.1× 84 1.0k
Jeffrey S. Baggish United States 12 192 0.6× 192 1.0× 126 0.7× 70 0.5× 7 0.1× 15 884
Jaime Díaz‐Guzmán Spain 14 107 0.3× 109 0.6× 117 0.6× 188 1.4× 17 0.1× 36 809
Carlos Cantú‐Brito Mexico 20 187 0.6× 134 0.7× 46 0.2× 190 1.4× 11 0.1× 121 1.2k
Kevin H.M. Kuo Canada 18 72 0.2× 142 0.7× 56 0.3× 51 0.4× 22 0.2× 153 1.3k
Stephanie R. Shaftman United States 18 158 0.5× 47 0.2× 223 1.2× 137 1.0× 27 0.2× 23 1.3k

Countries citing papers authored by Clark Paramore

Since Specialization
Citations

This map shows the geographic impact of Clark Paramore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clark Paramore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clark Paramore more than expected).

Fields of papers citing papers by Clark Paramore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clark Paramore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clark Paramore. The network helps show where Clark Paramore may publish in the future.

Co-authorship network of co-authors of Clark Paramore

This figure shows the co-authorship network connecting the top 25 collaborators of Clark Paramore. A scholar is included among the top collaborators of Clark Paramore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clark Paramore. Clark Paramore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Herring, William L., Nirmish Shah, Deirdre Mladsi, et al.. (2024). Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States. PharmacoEconomics. 42(6). 693–714. 7 indexed citations
2.
Feldman, M., Neil Hawkins, Shujun Li, et al.. (2021). Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia. SHILAP Revista de lepidopterología. 9(1). 1922028–1922028. 14 indexed citations
3.
4.
Paramore, Clark, et al.. (2020). Patient- and Caregiver-Reported Burden of Transfusion-Dependent β-Thalassemia Measured Using a Digital Application. Patient. 14(2). 197–208. 21 indexed citations
5.
Paramore, Clark, Andrew C. Dietz, & Luke Boulanger. (2020). PND48 COSTS OF EPISODES OF CARE FOR ALLOGENEIC TRANSPLANT FOR THE THE TREATMENT OF CEREBRAL ADRENOLEUKODYSTROPHY IN THE U.S.. Value in Health. 23. S268–S268. 1 indexed citations
6.
Paramore, Clark, et al.. (2020). Co‐morbidities and mortality associated with transfusion‐dependent beta‐thalassaemia in patients in England: a 10‐year retrospective cohort analysis. British Journal of Haematology. 191(5). 897–905. 23 indexed citations
7.
8.
9.
10.
Paramore, Clark, et al.. (2018). PSY33 - FEASIBILITY OF EVALUATING THE BURDEN OF B-THALASSEMIA WITH GERMAN CLAIMS DATA. Value in Health. 21. S441–S441. 2 indexed citations
11.
Matza, Louis S., et al.. (2018). PSY191 - HEALTH STATE UTILITIES ASSOCIATED WITH TREATMENT FOR TRANSFUSION DEPENDENT B-THALASSEMIA. Value in Health. 21. S469–S469. 1 indexed citations
12.
Paramore, Clark, et al.. (2018). Treatment Patterns and Costs of Care in Commercially-Insured and Medicaid Patients with Transfusion-Dependent SS-Thalassemia. Value in Health. 21. S262–S262. 3 indexed citations
13.
Paramore, Clark, et al.. (2018). Characterizing a Population with Severe Manifestations of Sickle Cell Disease Using U.S. Real-World Evidence. Blood. 132(Supplement 1). 4811–4811. 1 indexed citations
14.
Ben‐Joseph, Rami, et al.. (2016). Opioid Treatment Patterns Following Prescription of Immediate-Release Hydrocodone. Journal of Managed Care & Specialty Pharmacy. 22(4). 358–366. 1 indexed citations
15.
Kimball, Alexa B., Don Robinson, Ying Wu, et al.. (2008). Cardiovascular Disease and Risk Factors among Psoriasis Patients in Two US Healthcare Databases, 2001–2002. Dermatology. 217(1). 27–37. 147 indexed citations
16.
Cohen, Russell D., et al.. (2008). Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002. Inflammatory Bowel Diseases. 14(6). 738–743. 117 indexed citations
17.
Boscoe, Audra, Clark Paramore, & Joseph G. Verbalis. (2006). Cost of illness of hyponatremia in the United States. Cost Effectiveness and Resource Allocation. 4(1). 10–10. 119 indexed citations
18.
Coyne, Karin S., Clark Paramore, Susan Grandy, et al.. (2006). Assessing the Direct Costs of Treating Nonvalvular Atrial Fibrillation in the United States. Value in Health. 9(5). 348–356. 328 indexed citations
19.
Matza, Louis S., Clark Paramore, & Manishi Prasad. (2005). A review of the economic burden of ADHD. Cost Effectiveness and Resource Allocation. 3(1). 5–5. 184 indexed citations
20.
Paramore, Clark, et al.. (2002). PIN4 ECONOMIC IMPACT OF RESPIRATORY SYNCYTIAL VIRUS INFECTION ON HEALTHCARE RESOURCE UTILIZATION AND COSTS IN THE UNITED STATES. Value in Health. 5(3). 257–257. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Signild Åsberg Breakdown of academic impact, for papers by T. Michelle Brown Breakdown of academic impact, for papers by Hassan Hosseini Breakdown of academic impact, for papers by Sofia Pedro Breakdown of academic impact, for papers by Amit Kumar Breakdown of academic impact, for papers by Jeffrey S. Baggish Breakdown of academic impact, for papers by Jaime Díaz‐Guzmán Breakdown of academic impact, for papers by Carlos Cantú‐Brito Breakdown of academic impact, for papers by Kevin H.M. Kuo Breakdown of academic impact, for papers by Stephanie R. Shaftman
Rankless by CCL
2026